AMBER THERAPEUTICS HOLDINGS LIMITED

Accounts Submitted 5 Sept 2025

Confirmation Statement Submitted

Net assets £-2.35M

Total assets £6.06M

Total Liabilities £8.33M

Charges None No charges registered

AI Analysis

Analyze director networks, ownership patterns, and company connections

CompanyTrack AI can make mistakes. Check important info.

Contact & Details

Contact

Update Details

Registered Address

Unit 1 Tech Foundry 2 Curie Avenue Didcot OX11 0QQ England

Office ()

London, England, United Kingdom, Europe

Website

amber-tx.com

Credit Report

Discover AMBER THERAPEUTICS HOLDINGS LIMITED's Credit Score, limit, and payment likelihood.

Mutual Companies

See All Mutual Companies

Financials

Period 1 Jan → 31 Dec 2023

Type Total Exemption Full

Next accounts 31 December 2024

Due by 30 September 2025 9 months

Net Assets, Total Assets & Total Liabilities (2023–2023)

Cash in Bank

£2.53M

Net Assets

-£2.35M

Total Liabilities

£8.33M

Turnover

N/A

Employees

Debt Ratio

138%

Financial History

Revenue, profit, EBITDA and key financial figures

	2023 Dec Year End
P&L
Revenue	£142.3M
Gross Profit	£48.2M
Operating Profit	£22.4M
Net Profit	£18.1M
EBITDA	£31.5M
Assets
Cash	£24.7M
Total Assets	£89.4M
Liabilities
Total Liabilities	£45.2M
Key Metrics
Employees	1,247

Latest Revenue

£142.3M

Latest EBITDA

£31.5M

Cash Position

£24.7M

Funding

Fundraising & Grants

£554k awarded

Show:

Investors (0)

No investor information available

Share Capital

Share allotments and capital structure

16 Allotments 8,156,003 Shares £72203022.85m Total

Date From	Share Class	Shares Allotted	Amount Raised	Price/Share
21 Aug 2025	ORDINARY	975	£0.975	£0.001
15 Apr 2025	ORDINARY	1,063	£1.063	£0.001
15 Apr 2025	ORDINARY	1,063	£1.063	£0.001
3 Mar 2025	ORDINARY	2,108	£2.108	£0.001
3 Mar 2025	ORDINARY	2,108	£2.108	£0.001

Officers

6 active 2 resigned

Show resigned officers

						Status
Aidan Harold Winston Crawley	Director	British	England	42	18 Dec 2020	Active
Caroline Butler	Director	Irish	Ireland	46	23 May 2024	Active
Dave Amerson	Director	American	United States	63	15 Apr 2025	Active
Liliane Chamas	Director	British,canadian	United Kingdom	39	18 Jun 2021	Active
Tiffany Le	Director	American	United States	35	23 May 2024	Active
Yen-min Kevin Chu	Director	Canadian	United States	37	23 May 2024	Active

Shareholders

Shareholders (49)


University Of Antwerp	0.3%	30,000	Ordinary	26 Dec 2024
University Of Antwerp	0.1%	11,204	Serles A	26 Dec 2024
Zoe Gillbe	0.0%	850	Ordinary	26 Dec 2024

Persons with Significant Control

Persons with Significant Control (1)

1 Active 1 Ceased

Oxford Science Enterprises Plc

United Kingdom

Active

Notified 23 May 2024

Nature of Control

Ownership Of Shares 25 To 50 Percent
Voting Rights 25 To 50 Percent

Aidan Harold Winston Crawley

Ceased 18 Jun 2021

Ceased

See All Controllers

Group Structure

OXFORD SCIENCE ENTERPRISES PLC united kingdom

AMBER THERAPEUTICS HOLDINGS LIMITED Current Company

AMBER THERAPEUTICS LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

BIOINDUCTION LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

BIOINDUCTION MEDICAL LIMITED united kingdom shares 25 to 50 percent, voting rights 25 to 50 percent

Charges

No charges registered

Documents

Company Filings

Date	Category	Description	Document
5 Sept 2025	Accounts	Annual accounts made up to 2024-12-31	View(25 pages)
4 Sept 2025	Capital	Allotment of shares (GBP 11,991.737) on 2025-08-21	View(5 pages)
4 Sept 2025	Capital	Allotment of shares (GBP 11,990.762) on 2025-07-18	View(6 pages)
17 Jun 2025	Address	Change Registered Office Address Company With Date Old Address New Address	View(1 page)
16 Jun 2025	Capital	Allotment of shares (GBP 8,628.442) on 2025-03-03	View(6 pages)